We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSLK
201
DELISTED
Bolt Projects Holdings
BSLK
$4.5M 0.12%
+22,362
New +$4.46M
CIIG
202
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
$4.49M 0.12%
440,701
+399,998
+983% +$4.02M
ZCAR
203
DELISTED
Zoomcar
ZCAR
$4.49M 0.12%
+218
New +$4.45M
MEKA
204
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$4.48M 0.12%
+449,500
New +$4.46M
CPTK
205
DELISTED
Crown PropTech Acquisitions
CPTK
$4.46M 0.12%
440,725
AVHI
206
DELISTED
Achari Ventures Holdings Corp I
AVHI
$4.43M 0.12%
433,979
IRBT
207
DELISTED
iRobot
IRBT
$4.41M 0.12%
+91,629
New +$4.84M
MSAC
208
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$4.4M 0.12%
439,000
+200,000
+84% +$2M
DPCS
209
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
$4.4M 0.12%
+428,370
New +$4.36M
AGGR
210
DELISTED
Agile Growth Corp
AGGR
$4.33M 0.12%
429,426
+25,300
+6% +$253K
NVSA
211
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$4.3M 0.12%
426,541
+348,850
+449% +$3.49M
NFYS
212
DELISTED
Enphys Acquisition Corp.
NFYS
$4.24M 0.12%
422,884
+172,884
+69% +$1.71M
SVNA
213
DELISTED
7 Acquisition Corp
SVNA
$4.17M 0.11%
+405,308
New +$4.12M
DISA
214
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
$4.12M 0.11%
+408,970
New +$4.09M
MTVC.U
215
DELISTED
Motive Capital Corp II Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
MTVC.U
$4.09M 0.11%
400,000
PACI.U
216
DELISTED
PROOF Acquisition Corp I Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
PACI.U
$4.07M 0.11%
400,000
ATAQ
217
DELISTED
Altimar Acquisition Corp III
ATAQ
$4.03M 0.11%
400,000
+250,000
+167% +$2.5M
TLGY
218
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
$3.93M 0.11%
383,325
IVCA
219
DELISTED
Investcorp India Acquisition Corp
IVCA
$3.92M 0.11%
+378,931
New +$3.87M
ASCB
220
DELISTED
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
$3.82M 0.1%
+373,019
New +$3.76M
AXAC
221
DELISTED
AXIOS Sustainable Growth Acquisition Corporation
AXAC
$3.68M 0.1%
+356,888
New +$3.65M
CORS
222
DELISTED
Corsair Partnering Corporation
CORS
$3.64M 0.1%
+365,841
New +$3.61M
MITA
223
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$3.62M 0.1%
+360,623
New +$3.59M
NRAC
224
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$3.6M 0.1%
356,458
+242,457
+213% +$2.43M
FTEV.U
225
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
$3.59M 0.1%
356,423

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.